 To determine whether Ozurdex implant can offer an efficacious alternative for treatment of macular edema in the setting of retinal vein occlusion when treatment with intravitreal bevacizumab Avastin,ranibizumab Lucentis, andor aflibercept Eylea have not demonstrated significant response. 